Axe Compute Inc., was incorporated in Minnesota on April 23, 2002 and re-incorporated in Delaware in 2013. The company is a knowledge and science driven company that applies artificial intelligence (" AI ") to support the discovery and development of optimal cancer therapies that can ultimately lead to more effective treatments and improve patient outcomes. The company uses AI and a proprietary biobank of 150,000 + tumor samples, classified by tumor type, to provide actionable insights on drug compounds to improve the drug discovery process and increase the probability of success of drug compounds. 

AGPU